Fixing the Leaky Pipe: How to Improve the Uptake of Patient-Reported Outcomes-Based Prognostic and Predictive Models in Cancer Clinical Practice.


Journal

JCO clinical cancer informatics
ISSN: 2473-4276
Titre abrégé: JCO Clin Cancer Inform
Pays: United States
ID NLM: 101708809

Informations de publication

Date de publication:
Sep 2023
Historique:
pmc-release: 17 11 2024
medline: 20 11 2023
pubmed: 17 11 2023
entrez: 17 11 2023
Statut: ppublish

Résumé

This discussion paper outlines challenges and proposes solutions for successfully implementing prediction models that incorporate patient-reported outcomes (PROs) in cancer practice. We organized a full-day multidisciplinary meeting of people with expertise in cancer care delivery, PRO collection, PRO use in prediction modeling, computing, implementation, and decision science. The discussions presented here focused on identifying challenges to the development, implementation and use of prediction models incorporating PROs, and suggesting possible solutions. Specific challenges and solutions were identified across three broad areas. (1) Understanding decision making and implementation: necessitating multidisciplinary collaboration in the early stages and throughout; early stakeholder engagement to define the decision problem and ensure acceptability of PROs in prediction; understanding patient/clinician interpretation of PRO predictions and uncertainty to optimize prediction impact; striving for model integration into existing electronic health records; and early regulatory alignment. (2) Recognizing the limitations to PRO collection and their impact on prediction: incorporating validated, clinically important PROs to maximize model generalizability and clinical engagement; and minimizing missing PRO data (resulting from both structural digital exclusion and time-varying factors) to avoid exacerbating existing inequalities. (3) Statistical and modeling challenges: incorporating statistical methods to address missing data; ensuring predictive modeling recognizes complex causal relationships; and considering temporal and geographic recalibration so that model predictions reflect the relevant population. Developing and implementing PRO-based prediction models in cancer care requires extensive multidisciplinary working from the earliest stages, recognition of implementation challenges because of PRO collection and model presentation, and robust statistical methods to manage missing data, causality, and calibration. Prediction models incorporating PROs should be viewed as complex interventions, with their development and impact assessment carried out to reflect this.

Identifiants

pubmed: 37976441
doi: 10.1200/CCI.23.00070
pmc: PMC10681558
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2300070

Références

Lancet Oncol. 2019 Dec;20(12):e685-e698
pubmed: 31797795
J Patient Rep Outcomes. 2022 May 14;6(1):50
pubmed: 35567663
J Am Med Inform Assoc. 2021 Sep 18;28(10):2128-2138
pubmed: 34333646
Stat Methods Med Res. 2013 Jun;22(3):278-95
pubmed: 21220355
J Am Med Inform Assoc. 2013 Jun;20(e1):e76-84
pubmed: 23470696
BMC Cancer. 2022 Jan 15;22(1):66
pubmed: 35033009
JAMIA Open. 2019 Apr;2(1):73-80
pubmed: 30976756
Stud Health Technol Inform. 2019 Aug 21;264:634-638
pubmed: 31438001
Support Care Cancer. 2022 Feb;30(2):1427-1439
pubmed: 34524527
Ann Oncol. 2012 Aug;23(8):2166-2172
pubmed: 22250183
Informatics (MDPI). 2020 Sep;7(3):
pubmed: 33274178
J Geriatr Oncol. 2019 Nov;10(6):847-858
pubmed: 31078444
BMJ Open. 2022 Dec 26;12(12):e064067
pubmed: 36572495
Ann Intern Med. 2019 Jan 1;170(1):51-58
pubmed: 30596875
Qual Life Res. 2012 Oct;21(8):1305-14
pubmed: 22048932
Clin Transl Radiat Oncol. 2022 Oct 03;37:137-144
pubmed: 36247687
Lancet. 2005 Jan 1-7;365(9453):82-93
pubmed: 15639683
Arch Dermatol Res. 2023 Aug;315(6):1473-1480
pubmed: 36469125
Health Qual Life Outcomes. 2010 Jan 25;8:10
pubmed: 20100332
J Clin Oncol. 2003 Mar 15;21(6):1133-8
pubmed: 12637481
Ann Oncol. 2015 Sep;26(9):1846-1858
pubmed: 25888610
Nat Commun. 2022 Oct 12;13(1):6026
pubmed: 36224187
BMC Cancer. 2022 Oct 19;22(1):1076
pubmed: 36261794
BMJ Open. 2021 Jul 9;11(7):e048008
pubmed: 34244270
BMJ. 2016 Jun 22;353:i3140
pubmed: 27334381
Ann Oncol. 2017 Sep 01;28(9):2305-2311
pubmed: 28911065
Support Care Cancer. 2018 Jan;26(1):41-60
pubmed: 28849277
J Med Internet Res. 2021 Dec 14;23(12):e26381
pubmed: 34904952
Ann Oncol. 2013 Feb;24(2):482-488
pubmed: 23028038
J Clin Oncol. 2011 Jun 10;29(17):2319-26
pubmed: 21555700
Lancet Oncol. 2009 Sep;10(9):865-71
pubmed: 19695956
Lancet Oncol. 2019 Jun;20(6):e313-e326
pubmed: 31162105
Eur Respir J. 2022 Sep 15;60(3):
pubmed: 35728976
Ann Intern Med. 2023 Jan;176(1):105-114
pubmed: 36571841
J Med Imaging Radiat Oncol. 2021 Oct;65(6):806-816
pubmed: 33973382
Clin Oncol (R Coll Radiol). 2022 Feb;34(2):102-113
pubmed: 34922799
Eur Urol. 2015 Jun;67(6):1142-1151
pubmed: 25572824
Palliat Med. 2009 Jan;23(1):29-39
pubmed: 18952746
Int J Med Inform. 2021 Dec 11;158:104659
pubmed: 34929545
Eur Spine J. 2018 Apr;27(4):799-805
pubmed: 29064040
J Clin Oncol. 2005 May 20;23(15):3552-61
pubmed: 15908666
Oncologist. 2019 Dec;24(12):e1371-e1380
pubmed: 31387949
Health Econ. 2016 May;25(5):515-28
pubmed: 25740592
PLoS Med. 2013;10(2):e1001381
pubmed: 23393430
J Clin Epidemiol. 2016 Oct;78:90-100
pubmed: 27045189
J Clin Oncol. 2016 Feb 20;34(6):557-65
pubmed: 26644527
ESMO Open. 2021 Dec;6(6):100292
pubmed: 34763251
Health Technol Assess. 2021 May;25(28):1-118
pubmed: 34018486
J Clin Oncol. 2013 Jul 10;31(20):2580-5
pubmed: 23733753
J Pain Symptom Manage. 2022 Feb;63(2):301-310
pubmed: 34371137
Ann Oncol. 2007 Jun;18(6):971-6
pubmed: 17043092
Eur J Cancer. 2006 Jan;42(1):55-64
pubmed: 16162404
JAMA. 1998 Jun 3;279(21):1709-14
pubmed: 9624023
BMC Health Serv Res. 2013 Jun 11;13:211
pubmed: 23758898
Nat Genet. 2019 Apr;51(4):584-591
pubmed: 30926966
BMJ Open. 2016 Jun 15;6(6):e010938
pubmed: 27311907
J Am Med Inform Assoc. 2022 Apr 13;29(5):983-989
pubmed: 35045179
Cancer Invest. 2002;20(7-8):1086-104
pubmed: 12449742
Psychooncology. 2013 Oct;22(10):2298-305
pubmed: 23508972
J Am Geriatr Soc. 2001 Dec;49(12):1691-9
pubmed: 11844005
AMIA Annu Symp Proc. 2018 Apr 16;2017:625-634
pubmed: 29854127
Intensive Care Med. 2014 Mar;40(3):361-9
pubmed: 24441670
Lancet Oncol. 2016 Sep;17(9):1203-16
pubmed: 27599138
J Am Med Inform Assoc. 2021 Sep 18;28(10):2265-2268
pubmed: 34244760
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
J Clin Oncol. 2021 Mar 1;39(7):734-747
pubmed: 33417506
Head Neck. 2018 May;40(5):1091-1100
pubmed: 29356179
Eur J Epidemiol. 2020 Jul;35(7):619-630
pubmed: 32445007
Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1391-1398
pubmed: 27315664
J Geriatr Oncol. 2019 Nov;10(6):926-930
pubmed: 31477512
J Med Internet Res. 2015 May 07;17(5):e111
pubmed: 25953059
Value Health. 2011 Dec;14(8):1101-8
pubmed: 22152180
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
J Clin Oncol. 2018 Aug 1;36(22):2326-2347
pubmed: 29782209
Cancer Treat Rev. 2018 Mar;64:30-39
pubmed: 29459248
PLOS Digit Health. 2022 Nov 16;1(11):e0000146
pubmed: 36812574
BMC Med Inform Decis Mak. 2011 Oct 14;11:62
pubmed: 21999201
BMC Med Res Methodol. 2018 Aug 28;18(1):87
pubmed: 30153796
Lancet Oncol. 2006 Nov;7(11):903-9
pubmed: 17081915
Eur Urol. 2018 Dec;74(6):796-804
pubmed: 30241973
Ann Oncol. 2022 Sep;33(9):878-892
pubmed: 35462007
Diagn Progn Res. 2021 Jan 11;5(1):1
pubmed: 33431065
Biometrics. 2012 Mar;68(1):129-37
pubmed: 22050039
JAMA. 2019 Jan 22;321(3):306-307
pubmed: 30667494
PLoS One. 2016 Aug 25;11(8):e0161407
pubmed: 27560380
NPJ Digit Med. 2022 Jan 10;5(1):2
pubmed: 35013569
JCO Clin Cancer Inform. 2022 Jan;6:e2100137
pubmed: 34985914
Value Health. 2008 May-Jun;11(3):509-21
pubmed: 18179659
PLoS One. 2018 Apr 3;13(4):e0195447
pubmed: 29614114
Diagn Progn Res. 2018 Jun 12;2:11
pubmed: 31093561
BMJ Glob Health. 2020 May;5(5):
pubmed: 32424012
J Pain Symptom Manage. 2017 May;53(5):962-970.e10
pubmed: 28062344
Scand J Med Sci Sports. 2021 May;31(5):999-1008
pubmed: 33089516
Lancet Digit Health. 2020 Sep;2(9):e489-e492
pubmed: 32864600
J Clin Oncol. 2011 Sep 1;29(25):3457-65
pubmed: 21810685
J Med Radiat Sci. 2021 Jun;68(2):186-195
pubmed: 32815314
J Clin Oncol. 2016 Jul 10;34(20):2366-71
pubmed: 27185838
Crit Rev Oncol Hematol. 2012 Oct;84(1):130-48
pubmed: 22465016
Crit Rev Oncol Hematol. 2023 Jan;181:103867
pubmed: 36427770
Clin Oncol (R Coll Radiol). 2020 Sep;32(9):553-561
pubmed: 32684503

Auteurs

Katie L Spencer (KL)

Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom.
Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.

Kate L Absolom (KL)

Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom.

Matthew J Allsop (MJ)

Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom.

Samuel D Relton (SD)

Leeds Institute of Data Analytics, University of Leeds, Leeds, United Kingdom.

Jessica Pearce (J)

Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom.

Kuan Liao (K)

Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, Centre for Health Informatics, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom.

Sairah Naseer (S)

School of Medicine, University of Leeds, Leeds, United Kingdom.

Omolola Salako (O)

College of Medicine, University of Lagos, Lagos, Nigeria.

Daniel Howdon (D)

Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom.

Jenny Hewison (J)

Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom.

Galina Velikova (G)

Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom.

Corinne Faivre-Finn (C)

Institute of Cancer Sciences, University of Manchester, Manchester, United Kingdom.

Hilary L Bekker (HL)

Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom.

Sabine N van der Veer (SN)

Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, Centre for Health Informatics, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH